RS65294B1 - Derivati alfa-d-galaktopiranozida - Google Patents
Derivati alfa-d-galaktopiranozidaInfo
- Publication number
- RS65294B1 RS65294B1 RS20240319A RSP20240319A RS65294B1 RS 65294 B1 RS65294 B1 RS 65294B1 RS 20240319 A RS20240319 A RS 20240319A RS P20240319 A RSP20240319 A RS P20240319A RS 65294 B1 RS65294 B1 RS 65294B1
- Authority
- RS
- Serbia
- Prior art keywords
- alpha
- galactopyranoside
- derivatives
- galactopyranoside derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/12—Triazine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP2019073063 | 2019-08-29 | ||
| EP20775188.4A EP4021904B1 (en) | 2019-08-29 | 2020-08-28 | Alpha-d-galactopyranoside derivatives |
| PCT/EP2020/074121 WO2021038068A1 (en) | 2019-08-29 | 2020-08-28 | Alpha-d-galactopyranoside derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS65294B1 true RS65294B1 (sr) | 2024-04-30 |
Family
ID=72561746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20240319A RS65294B1 (sr) | 2019-08-29 | 2020-08-28 | Derivati alfa-d-galaktopiranozida |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20220281855A1 (sr) |
| EP (1) | EP4021904B1 (sr) |
| JP (1) | JP2022546029A (sr) |
| KR (1) | KR20220053622A (sr) |
| AU (1) | AU2020338816A1 (sr) |
| BR (1) | BR112022003562A2 (sr) |
| CA (1) | CA3148365A1 (sr) |
| ES (1) | ES2972551T3 (sr) |
| HR (1) | HRP20240297T1 (sr) |
| HU (1) | HUE066221T2 (sr) |
| IL (1) | IL290815A (sr) |
| MA (1) | MA57000B1 (sr) |
| MX (1) | MX2022002339A (sr) |
| PL (1) | PL4021904T3 (sr) |
| RS (1) | RS65294B1 (sr) |
| SA (1) | SA522431777B1 (sr) |
| TW (1) | TW202122092A (sr) |
| WO (1) | WO2021038068A1 (sr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116348463A (zh) | 2020-10-06 | 2023-06-27 | 爱杜西亚药品有限公司 | α-D-吡喃半乳糖苷的螺衍生物 |
| AU2022228660A1 (en) | 2021-03-03 | 2023-10-19 | Idorsia Pharmaceuticals Ltd | Triazolyl-methyl substituted alpha-d-galactopyranoside derivatives |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE0100172D0 (sv) | 2001-01-22 | 2001-01-22 | Ulf Nilsson | New inhibitors against galectins |
| SE0401300D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel Galactoside Inhibitors of Galectins |
| SE0401301D0 (sv) | 2004-05-21 | 2004-05-21 | Forskarpatent I Syd Ab | Novel 3-triazolyl-galactoside inhibitors of galectins |
| CN104822382B9 (zh) | 2012-10-10 | 2019-01-18 | 卡莱克汀医疗有限公司 | 用于治疗糖尿病性肾病和相关疾病的半乳糖分支的糖类化合物 |
| CN104755088A (zh) | 2012-10-31 | 2015-07-01 | 格莱克特生物技术公司 | 半乳凝集素-3的半乳糖苷抑制剂及其用于治疗肺纤维化的应用 |
| EP2919802A4 (en) | 2012-11-15 | 2016-09-14 | Univ Tufts | METHOD, COMPOSITIONS AND KITS FOR TREATING, MODULATING OR PREVENTING ANGIOGENESIS OR FIBROSIS IN A PATIENT USING A GALECTINE PROTEIN HEMMER |
| JP6904906B2 (ja) | 2015-01-30 | 2021-07-21 | ガレクト・バイオテック・エイビイ | ガレクチンの新規なガラクトシド阻害剤 |
| WO2017007689A1 (en) | 2015-07-06 | 2017-01-12 | Gilead Sciences, Inc. | Cot modulators and methods of use thereof |
| CA3062648A1 (en) | 2017-05-12 | 2018-11-15 | Galectin Sciences, Llc | Compounds for the prevention and treatment of diseases and the use thereof |
| US20200061095A1 (en) | 2017-05-12 | 2020-02-27 | Galectin Sciences, Llc | Compounds for the Treatment of Systemic Insulin Resistance Disorders and the Use Thereof |
| US11267811B2 (en) | 2017-09-27 | 2022-03-08 | Bristol-Myers Squibb Company | Small molecule inhibitors of galectin-3 |
| WO2019075045A1 (en) | 2017-10-11 | 2019-04-18 | Bristol-Myers Squibb Company | INHIBITORS WITH SMALL MOLECULES OF GALECTIN-3 |
| KR20200081443A (ko) | 2017-10-31 | 2020-07-07 | 갈랙틴 사이언시즈, 엘엘씨 | 전신성 인슐린 저항성 질환의 치료를 위한 셀레노갈락토사이드 화합물 및 이의 용도 |
| EP3867260A1 (en) | 2018-10-15 | 2021-08-25 | Galecto Biotech AB | Galactoside inhibitor of galectins |
| CA3114055A1 (en) | 2018-10-15 | 2020-04-23 | Galecto Biotech Ab | Prodrug of galactoside inhibitors of galectins |
| CA3116515A1 (en) | 2018-11-21 | 2020-05-28 | Galecto Biotech Ab | Alpha-d-galactoside inhibitors of galectins |
-
2020
- 2020-08-28 PL PL20775188.4T patent/PL4021904T3/pl unknown
- 2020-08-28 MA MA57000A patent/MA57000B1/fr unknown
- 2020-08-28 RS RS20240319A patent/RS65294B1/sr unknown
- 2020-08-28 WO PCT/EP2020/074121 patent/WO2021038068A1/en active Application Filing
- 2020-08-28 HR HRP20240297TT patent/HRP20240297T1/hr unknown
- 2020-08-28 CA CA3148365A patent/CA3148365A1/en active Pending
- 2020-08-28 TW TW109129635A patent/TW202122092A/zh unknown
- 2020-08-28 AU AU2020338816A patent/AU2020338816A1/en active Pending
- 2020-08-28 ES ES20775188T patent/ES2972551T3/es active Active
- 2020-08-28 US US17/638,799 patent/US20220281855A1/en active Pending
- 2020-08-28 JP JP2022512854A patent/JP2022546029A/ja active Pending
- 2020-08-28 MX MX2022002339A patent/MX2022002339A/es unknown
- 2020-08-28 BR BR112022003562A patent/BR112022003562A2/pt unknown
- 2020-08-28 KR KR1020227009790A patent/KR20220053622A/ko unknown
- 2020-08-28 EP EP20775188.4A patent/EP4021904B1/en active Active
- 2020-08-28 HU HUE20775188A patent/HUE066221T2/hu unknown
-
2022
- 2022-02-22 IL IL290815A patent/IL290815A/en unknown
- 2022-02-27 SA SA522431777A patent/SA522431777B1/ar unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA3148365A1 (en) | 2021-03-04 |
| ES2972551T3 (es) | 2024-06-13 |
| MA57000B1 (fr) | 2024-03-29 |
| US20220281855A1 (en) | 2022-09-08 |
| TW202122092A (zh) | 2021-06-16 |
| WO2021038068A1 (en) | 2021-03-04 |
| HRP20240297T1 (hr) | 2024-05-10 |
| HUE066221T2 (hu) | 2024-07-28 |
| EP4021904A1 (en) | 2022-07-06 |
| SA522431777B1 (ar) | 2024-04-30 |
| KR20220053622A (ko) | 2022-04-29 |
| PL4021904T3 (pl) | 2024-05-13 |
| AU2020338816A1 (en) | 2022-04-14 |
| EP4021904C0 (en) | 2024-01-03 |
| CN114585619A (zh) | 2022-06-03 |
| EP4021904B1 (en) | 2024-01-03 |
| BR112022003562A2 (pt) | 2022-05-24 |
| JP2022546029A (ja) | 2022-11-02 |
| MX2022002339A (es) | 2022-04-06 |
| IL290815A (en) | 2022-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA189498S (en) | Showerbase | |
| ZA202204675B (en) | New methylquinazolinone derivatives | |
| IL283990A (en) | Modified oxopyridine derivatives | |
| CA191618S (en) | Floorwasher - nozzle | |
| IL289197A (en) | History of 2-hydroxycycloalkane-1-carbamoyl | |
| SI3796975T1 (sl) | Derivati sulfonilaminobenzamida | |
| CA187781S (en) | Banquette | |
| IL279938A (en) | History of spirochroman | |
| IL290964A (en) | A 2-aminoquinazolinone derivative | |
| IL290815A (en) | History of alpha-d-galactopyranoside | |
| CA190552S (en) | Hand-dryer | |
| CA189795S (en) | Handshower | |
| CA189675S (en) | Uroflowmeter | |
| CA193248S (en) | Mandoline | |
| CA190385S (en) | Beverageware | |
| CA190384S (en) | Beverageware | |
| CA189047S (en) | Hammock-tent | |
| HUE062256T2 (hu) | Dihidrokromén-származékok | |
| CA194482S (en) | Kick-scooter | |
| GB201919210D0 (en) | Dihydro-cyclopenta-isoquinoline derivatives | |
| GB201919213D0 (en) | Dihydrocyclopenta-Isoquinoline-Sulfanamide derivatives compounds | |
| CA192228S (en) | Hydrogenerator | |
| CA190974S (en) | Hoodie | |
| CA190386S (en) | Beverageware | |
| CA190387S (en) | Beverageware |